Atypical Presentation of Herpes Simplex 1 Virus in a COVID-19 Patient

Maria José Guimarães; Filomena Azevedo; Carmen Lisboa

doi:10.29021/spdv.79.4.1408

Maria José Guimarães Department of Dermatology and Venereology, Hospital de Braga, EPE, Braga, Portugal https://orcid.org/0000-0002-3247-2470
Filomena Azevedo Department of Dermatology and Venereology, Centro Hospitalar Universitário S. João, Porto, Portugal https://orcid.org/0000-0003-0402-6382
Carmen Lisboa Department of Dermatology and Venereology, Centro Hospitalar Universitário S. João, Porto, Portugal; Division of Microbiology, Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal https://orcid.org/0000-0001-8247-8902

DOI: https://doi.org/10.29021/spdv.79.4.1408

Keywords: COVID-19, Herpesvirus 1, Human

Downloads

Download data is not yet available.

References

Garrido PM, Borges-Costa J. Manifestações clínicas atípicas de infeção genital pelos vírus herpes simplex e sua abordagem terapêutica. J Port Soc Dermatol Venereol. 2018;76:65–70.

Ogawa Y, Higuchi T, Koyamada R, Arai S, Okada S. Hypertrophic herpes simplex virus type 1 infection in a patient with acute myeloid leukemia. J Hematol. 2017;6:68–71. doi: 10.14740/jh333w.

Majtanova N, Kriskova P, Keri P, Fellner Z, Majtan J, Kolar P. Herpes simplex keratitis in patients with SARS-CoV-2 infection: a series of five cases. Medicina. 2021;57:412. doi: 10.3390/medicina57050412.

Tyring S, Carlton S, Evans T. Herpes . Atypical clinical manifestations. Dermatol Clin. 1998;16:783–8.

Sbidian E, Battistella M, LeGoff J, Lafaurie M, Bézier M, Agbalika F, et al. Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for pre- dominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategy. Clin Infect Dis.2013;57:1648–55. doi: 10.1093/cid/cit592.